Share Email Print

Proceedings Paper

Classification of breast calcifications in dual-energy FFDM using a convolutional neural network: simulation study
Format Member Price Non-Member Price
PDF $17.00 $21.00

Paper Abstract

Based on chemical composition, two types of microcalcifications are found within the breast. Type I calcifications consist of calcium oxalate (CaOx), whereas Type II calcifications are composed of calcium phosphates, mainly hydroxyapatite (CaHa). Previous tissue analysis studies1, 2 have shown that Type I calcifications are typically found in benign lesions, and are not associated with carcinoma. Type II calcifications, on the other hand, can be found in both benign and malignant breast lesions. It was estimated1 that lesions with solely Type I calcifications represented 12-17% of benign biopsies performed. Therefore, an imaging method that could differentiate calcified lesions with solely CaOx calcifications might help in reducing unnecessary breast biopsies. Previous studies3-5 have shown that dual-energy mammography can be an effective tool in discriminating between these two classes of calcifications. In this work we investigate if a convolutional neural network (CNN) can be trained to distinguish between these two types of calcified clusters, using dual-energy x-ray mammograms. We implement a Monte Carlo mammography simulator package to model a dual-energy FFDM system and use a realistic anthropomorphic digital breast phantom model6 with embedded microcalcifications. A Resnet CNN architecture was used to classify the ROIs containing either CaOX, or CaOx clusters. We report classification accuracy results in terms ROC curve and the corresponding area under it.

Paper Details

Date Published: 16 March 2020
PDF: 6 pages
Proc. SPIE 11312, Medical Imaging 2020: Physics of Medical Imaging, 113120M (16 March 2020); doi: 10.1117/12.2548454
Show Author Affiliations
Andrey Makeev, Food and Drug Administration (United States)
Bahaa Ghammraoui, Food and Drug Administration (United States)
Andreu Badal, Food and Drug Administration (United States)
Christian G. Graff, Food and Drug Administration (United States)
Stephen J. Glick, Food and Drug Administration (United States)

Published in SPIE Proceedings Vol. 11312:
Medical Imaging 2020: Physics of Medical Imaging
Guang-Hong Chen; Hilde Bosmans, Editor(s)

© SPIE. Terms of Use
Back to Top
Sign in to read the full article
Create a free SPIE account to get access to
premium articles and original research
Forgot your username?